This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Articles

Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder.

 

Published: March 15, 2003

Article Abstract
Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder. [CME]

Joseph Biederman, M.D., opened the symposium by reviewing the history of attention-deficit/hyperactivity disorder (ADHD), neurologic impairment in individuals with ADHD, and the prevalence of the disorder and comorbid conditions. Dr. Biederman also explained how, together, symptoms and comorbid conditions result in the impairments associated with ADHD.

Volume: 64

Quick Links: ADHD , Neurodevelopmental

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...